ALP Bio
Developer of immune organoid and AI platform to identify, understand, and reduce immunogenicity risk earlier in antibody development
Seedtable Score
18
Startups
1
Funding Rounds
$2.2m
Money raised
Overview
Developer of immune organoid and AI platform to identify, understand, and reduce immunogenicity risk earlier in antibody development
- Website:
- Headquarters: Zürich
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Lu*** Sc**** | - | - | |
| An**** Eh***** | - | - | |
| Pu*** Me*** | - | - | |
| Ch******* Va********* | - | - |
Funding series
Funding Series Analysis
The company ALP Bio has raised a total of $2.2m in funding over 1 rounds.
Key Insights:
- ALP Bio Pre-Seed Round, April 2026: $2.2m
ALP Bio Pre-Seed Round, April 2026
$2.2m
Industries
ALP Bio is active in the following industries: